Utikal, Jochen 1974-
Jochen Utikal
Utikal, Jochen S.
VIAF ID: 268302420 (Personal)
Permalink: http://viaf.org/viaf/268302420
Preferred Forms
-
100 0 _ ‡a Jochen Utikal
-
100 1 _ ‡a Utikal, Jochen S.
-
-
100 1 _ ‡a Utikal, Jochen ‡d 1974-
-
100 1 _ ‡a Utikal, Jochen ‡d 1974-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients |
![]() |
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification |
![]() |
Deep learning can predict survival directly from histology in clear cell renal cell carcinoma |
![]() |
Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists |
![]() |
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma |
![]() |
Effects of Label Noise on Deep Learning-Based Skin Cancer Classification |
![]() |
efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : a retrospective multicenter study |
![]() |
Eosinophils as biomarker in melanoma immunotherapy and solid tumors |
![]() |
Ethical challenges in cancer diagnosis and therapy, [2021]: |
![]() |
Gastrointestinal cancer classification and prognostication from histology using deep learning Systematic review |
![]() |
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study |
![]() |
Identifizierung prädiktiver Biomarker für die Immuntherapie mit PD-1-Antikörpern beim metastasierten malignen Melanom |
![]() |
Immune Checkpoint Blockade for Metastatic Uveal Melanoma Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis |
![]() |
Immunhistochemische Untersuchung prognostischer Marker beim malignen Melanom |
![]() |
Immunohistochemical analysis of potentially targetable markers in histiocytic disorders |
![]() |
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study. |
![]() |
Improved survival with MEK inhibition in BRAF-mutated melanoma |
![]() |
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy |
![]() |
Leukocyte count restoration under dabrafenib treatment in a melanoma patient with vemurafenib-induced leukopenia: case report. |
![]() |
Local cutaneous argyria mimicking melanoma metastases in a patient with disseminated melanoma |
![]() |
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation |
![]() |
Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens. |
![]() |
Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives. |
![]() |
Model soups improve performance of dermoscopic skin cancer classifiers |
![]() |
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes |
![]() ![]() |
mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model |
![]() |
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival |
![]() ![]() |
Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy. |
![]() |
Multiple roles of NF1 in the melanocyte lineage |
![]() |
Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib |
![]() |
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. |
![]() |
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model. |
![]() |
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. |
![]() |
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway |
![]() |
Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer |
![]() |
The oak processionary moth: a new health hazard? |
![]() |
Oncogenic role of an epigenetic reader of m6A RNA modification: YTHDF1 in Merkel cell carcinoma |
![]() |
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians. |
![]() |
Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma |
![]() |
Persistent facial erythema and edema |
![]() |
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. |
![]() |
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma |
![]() ![]() |
PIEZO2 is required for mechanotransduction in human stem cell-derived touch receptors. |
![]() |
Predominant telangiectatic erythema in linear atrophoderma of Moulin: novel variant or separate entity? |
![]() |
Primary tumor–derived systemic nANGPTL4 inhibits metastasis |
![]() |
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. |
![]() |
Real-World Therapy with Pembrolizumab Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany |
![]() |
The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells |
![]() |
[Red and purple maculas and plaques at the lateral aspects of the thighs]. |
![]() |
Reiter's syndrome-like pattern in AIDS-associated psoriasiform dermatitis |
![]() |
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression |
![]() |
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas |
![]() |
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression |
![]() |
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) |
![]() |
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study. |
![]() |
Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas. |
![]() |
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma |
![]() |
Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. |
![]() |
Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes |
![]() |
The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation |
![]() |
Single cell polarity in liquid phase facilitates tumour metastasis. |
![]() |
[Single center analysis of the dermatosurgical patient cohort of a tumor center in Germany] |
![]() |
Skin cancer classification via convolutional neural networks systematic review of studies involving human experts |
![]() |
SOX10 downregulation in tumor cells affects extracellular vesicle production and function in the tumor microenvironment |
![]() |
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma |
![]() |
SOX5 is involved in balanced MITF regulation in human melanoma cells. |
![]() |
STAT3 – the switch of melanoma-associated NRAS mutations |
![]() |
Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells. |
![]() |
Systemic therapy of non-resectable metastatic melanoma |
![]() |
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin |
![]() |
Tackling malignant melanoma epigenetically: histone lysine methylation |
![]() |
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe) |
![]() |
Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts |
![]() ![]() |
Targeting SOX2 in anticancer therapy |
![]() |
The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. |
![]() |
TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells |
![]() |
Timed Ang2-targeted therapy identifies the Angiopoietin–tie pathway as key regulator of fatal lymphogenous metastasis |
![]() ![]() |
Topography of cancer-associated immune cells in human solid tumors |
![]() ![]() |
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial |
![]() |
Treatment of gunpowder tattoos with a high-speed diamond drill |
![]() |
Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany. |
![]() |
Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma |
![]() |
Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment |
![]() |
Willingness to pay for a cure of low-risk melanoma patients in Germany |
![]() ![]() |
Zweites Netzwerktreffen der zertifizierten Hauttumorzentren |
![]() |